Zobrazeno 1 - 8
of 8
pro vyhledávání: '"A. J.-C. Lue"'
Publikováno v:
Journal of Physics and Chemistry of Solids. 62:1813-1818
We have measured the low-temperature resistivities of a series of bulk crystalline disordered Ti 73− x Al 27 Sn x alloys ( x ≲5) as well as the sheet resistances of a number of thin ferromagnetic Ni films (≈120 A thick) sandwiching an ultrathin
Publikováno v:
Scopus-Elsevier
The mechanical properties of the lateral wall of the guinea pig cochlear outer hair cell were studied using the micropipette aspiration technique. A fire-polished micropipette with an inner diameter of approximately 4 microm was brought into contact
Autor:
A R, Shalita, D K, Chalker, R F, Griffith, A A, Herbert, J G, Hickman, J M, Maloney, B H, Miller, E H, Tschen, R A, Chandraratna, J R, Gibson, D A, Lew-Kaya, J C, Lue, J, Sefton
Publikováno v:
Cutis. 63(6)
Retinoids reverse the abnormal pattern of keratinization seen in acne vulgaris. Tazarotene is the first of a novel family of topical receptor-selective acetylenic retinoids. This study evaluates the safety and efficacy of topical tazarotene 0.1% and
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 9:S124
Publikováno v:
Second European Glaucoma Symposium, Helsinki, May 1984 ISBN: 9789401089340
Levobunolol is a new non-cardioselective beta-adrenoceptor antagonist. Such agents are rapidly gaining acceptance in the treatment of elevated intraocular pressure (IOP). Levobunolol has been shown to have a long duration of action, and is well absor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4cd1df9862be4660fa5c89d386b1eac0
https://doi.org/10.1007/978-94-009-5516-5_27
https://doi.org/10.1007/978-94-009-5516-5_27
Publikováno v:
Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde. 197(2)
We evaluated the efficacy and safety of 0.5% levobunolol HC1 (Vistagan) in 2,041 glaucoma patients at 143 sites in the Federal Republic of Germany. This study was a 3-month, open-label, noncomparative trial of levobunolol administered twice daily. Ei
Autor:
A D, Charap, D H, Shin, G, Petursson, D, Cinotti, E, Wortham, R H, Brown, D E, Silverstone, J M, Atkins, C Y, Eto, J C, Lue
Publikováno v:
Annals of ophthalmology. 21(9)
We studied the effects on efficacy and safety of varying the drop size of a topical solution of levobunolol 0.5%. In a double-masked, crossover acute study, we administered a single drop of either 35 microL of vehicle, or 20, 35, or 50 microL of levo
Autor:
G D Novack, J C Lue, E Voepel, K P Schunck, G K Krieglstein, E P Glavinos, U Lange, G Schwarzbach
Publikováno v:
Scopus-Elsevier
Topical levobunolol 0.5% was compared with topical metipranolol 0.6% for efficacy, safety, and comfort in 46 patients with open angle glaucoma or ocular hypertension. The study was of parallel design, randomised, double-masked, and of three months' d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a3a6434bde5fbd3e49092284330bfe2
http://www.scopus.com/inward/record.url?eid=2-s2.0-0023115879&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0023115879&partnerID=MN8TOARS